Scientific Statement for Screening of Coronary Artery Disease in Patients with Ischemic Stroke.
- Author:
Dongbeom SONG
1
;
Young Dae KIM
;
Keun Sik HONG
;
Byung Woo YOON
;
Byung Chul LEE
;
Joung Ho RHA
;
Sun Uck KWON
;
Hee Joon BAE
;
Kyung Ho YU
;
Jong Moo PARK
;
Kwang Yeol PARK
;
Sang Bae KO
;
Chang Wan OH
;
Jeong Eun KIM
;
Ji Hoe HEO
Author Information
- Publication Type:Review
- Keywords: Ischemic stroke; Myocardial infarction; Coronary artery disease; Screening; Scientific statement
- MeSH: Angiography; Contrast Media; Coronary Artery Disease*; Coronary Vessels*; Echocardiography, Stress; Humans; Hypersensitivity; Mass Screening*; Mortality; Myocardial Infarction; Myocardial Perfusion Imaging; Renal Insufficiency; Risk Factors; Stroke*
- From:Journal of the Korean Neurological Association 2016;34(2):91-98
- CountryRepublic of Korea
- Language:Korean
- Abstract: Ischemic stroke and myocardial infarction share common risk factors and pathophysiologic mechanisms. Unrecognized coronary artery disease typically occurs in 20-30% of patients with ischemic stroke, and its presence helps to predict the outcome. Coronary artery disease is also an important cause of morbidity and mortality in patients with ischemic stroke. Therefore, applying a screening test for asymptomatic coronary artery disease may be considered in ischemic stroke patients who have a high cardiovascular risk profile. Coronary computed tomography (CT) angiography, myocardial perfusion imaging, or stress echocardiography can be used as a screening test. Coronary CT angiography is recommended in the absence of allergy to contrast media and renal insufficiency.
